Lauri Strauss Memorial Grand Round Lectures
Delivered Annually at Memorial Sloan Kettering Cancer Center, New York, NY
Guest Lecturer 2024
Saar Gill, MD, Ph.D
Scientific Co-Director, Cell Therapy and Transplant Program Associate Professor of Medicine (Hematology-Oncology)
“CD45 gene edited hematopoietic stem cell transplantation as a versatile immunotherapy platform”
The Hospital of the University of Pennsylvania
Guest Lecturer – 2023
Mount Sinai Health System, New York
The Albert A. and Vera G. List Professor of Medicine, Prof of Medicine (Hematology and Medical Oncology), and Director of the Myeloproliferative Disorders Research Program.
Dr, Richard J. O’Reilly, MD
Guest Lecturer – 2018
Memorial Sloan Kettering Cancer Center
New York, NY
Adoptive Immunotherapy for Viral Malignancies and Infections
Dr. Benjamin Ebert, MD, PhD
Guest Lecturer – 2017
Dana-Farber Cancer Institute
Boston, MA
The genetics of myeloid neoplasia: from clonal
hematopoiesis to acute leukemia
Ravinda Majeti, MD – 2015-2016
Associate Prof. of Medicine (Hematology)
Stanford School of Medicine
Stanford, CA
AML Stem Cells: Biology, Clinical Significance, and Therapeutic Targeting
Ross Levine, MD – 2014-2015
Memorial Sloan Kettering Cancer Center
New York, NY
The Genetics and Therapeutics of Acute Myeloid Leukemia(AML)
Scott Armstrong, MD – 2013-2014
Memorial Sloan Kettering Cancer Center,
New York, NY
Targeting Histone methylation for Leukemia
Donald Small, MD, PhD – 2012-2013
“TITLE TO ADD”
Delivered at Memorial Sloan Kettering Cancer Center
New York, NY
Sidney Kimmel Comprehensive Cancer Center
Kenneth C. Anderson, MD – 2008-2009
Dana Farber Cancer Institute
Boston, MA
Oncogenomics To Target Myeloma in the Bone
Marrow Microenvironment
Martin Tallman, MD – 2010-2011
Memorial Sloan Kettering Cancer Center
New York, NY
Crossing the Great Divide in Acute Myeloid Leukemia
Hagop M. Kantarjian, MD – 2004-2005
M.D. Anderson Cancer Center
Houston, TX
A Tale of Two Nucleosides:
Decitabine
Charles L. Sawyers, MD – 2006-2007
Memorial Sloan Kettering Cancer Center
New York, NY
Kinase Inhibitors: Lessons from Chronic
Myeloid Leukemia
Jonathan D. Licht, MD – 2002-2003
Feinberg School of Medicine, Northwestern University
Chicago, IL
Targeting Transcriptional Repression in Hematological Malignancy
George J. Weiner, MD – 2003 – 2004
Holden Comprehensive Cancer Center
Iowa City, IA
Immunotherapy of B-cell Malignancies with Monoclonal Antibodies and Immuno Stimulatory CpG ODN
Alan D. D’Andrea, MD – 2000 – 2001
Harvard Medical School
Boston, MA
Inherited Chromosome Instability and Cancer
Irwin D. Bernstein, MD – 2001 – 2002
Fred Hutchinson Cancer Research Center
University of Washington School of Medicine,
Children’s Hospital and Regional Medical Center
Seattle, WA
Notch Regulation of Hematopoietic Stem Cells
Richard Champlin, MD – 1998 – 1999
M.D. Anderson Cancer Center
Houston, TX
Advances in
Transplantation for Leukemia
Rick VanEtten, MD, PhD – 1999 – 2000
Tufts-New England Medical Center
Boston, MA
Transformation and Leukemogenesis by the Abl Tyrosine Kinase
A. Thomas Look, MD – 1996 – 1997
Dana Farber Cancer Institute
Harvard Medical School
Boston, MA
Reversal of Apoptosis by Leukemia
Associated E2a-
Kenneth Kaushansky, MD – 1998 – 1999
University of California
San Diego School of Medicine
San Diego, CA
Thrombopoietin from Theory to Reality
Jerome Ritz, MD – 1993 – 1994
Dana-Farber Cancer Institute
Harvard Medical School
Boston, MA
The Use of Low Dose Interleukin-2 in the Treatment of Cancer
Ernest Beutler, MD – 1995 – 1996
The Scripps Research Institute
Scripps Clinic Medical Group
La Jolla, CA
2-Chlorodeoxyadenosine (2CdA):
The Unconventional Development of a New Drug
Donall Thomas, MD – 1991 – 1992
Nobel Laureate, University of Washington
Fred Hutchinson Cancer Research Center
Seattle, WA
Bone Marrow Transplantation: An Overview
Alessandro Massimo Gianni, MD – 1993 – 1992
Instituto Nazionale Tumori
Milan, Italy
Clinical Usefulness of Peripheral Blood
Progenitor Cells
Albert Deisseroth, MD, PhD – 1990 – 1991
The Sidney Kimmel Cancer Center
San Diego, CA
New Advances in Treatment of AML
Jimmie Holland, MD – 1991 – 1990
Memorial Sloan Kettering Cancer Center
New York, NY
Psychological Dimensions of Cancer: Old Issues
New Challenges